This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 1991;265(11):1423-1425.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

RECOMBINANT bovine somatotropins (rBST) are biosynthetic versions of the naturally occurring pituitary hormone in cows. They also are known as bovine growth hormone (bGH). Bovine somatotropin differs in structure from human pituitary growth hormone and is biologically inactive in humans. Recombinant bovine somatotropin increases milk production in cows. Treatment of dairy cows with rBST has generated a great deal of controversy and public interest. Questions have been raised about possible adverse health effects of the consumption of milk and meat from rBST-supplemented animals and of the treatment of dairy cows.

To assess these issues, the National Institute of Child Health and Human Development, the National Institute of Diabetes and Digestive and Kidney Diseases, the Division of Nutrition Research Coordination, and the Office of Medical Applications of Research of the National Institutes of Health convened the Technology Assessment Conference on Bovine Somatotropin from December 5-7, 1990. A panel was charged with . . . [Full Text PDF of this Article]

Footnotes
From the Office of Medical Applications of Research, Bldg 1, Room 260, National Institutes of Health, Bethesda, Md.

Reprint requests to Office of Medical Applications of Research, Bldg 1, Room 260, National Institutes of Health, Bethesda, MD 20892 (William H. Hall).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?